Beam Therapeutics Inc. has grown revenue 25% a year over three years and 479% a year over five. Revenue growth, 3-year annual rate: +25% (Biotechnology median +17%). Revenue growth, 5-year rate: +479%, growth has slowed since the five-year average. Years of annual history on file: 7, FY2019 to FY2025, as filed.

BEAMBeam Therapeutics Inc.

Healthcare

$25.71+5.7% 1Y

$25.71

$20.6052 weeks$35.53

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +159% year on year, but operating margin narrowing (−5848.2 points).

1 good, 1 to watch, 1 without data

Revenue trend+159% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +479% a year.

Margin direction−5848.2 points operating

Trailing-twelve-month operating margin, -6872.0% now against -1023.8% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BEAM growing?

Beam Therapeutics Inc. has grown revenue 25% a year over three years and 479% a year over five.

+25%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +479%
Revenue growth, 5-year rate · +25% over three · growth has slowed since the five-year average
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›